These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 29219119)

  • 1. Density overwrites of internal tumor volumes in intensity modulated proton therapy plans for mobile lung tumors.
    Botas P; Grassberger C; Sharp G; Paganetti H
    Phys Med Biol; 2018 Jan; 63(3):035023. PubMed ID: 29219119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel four-dimensional radiotherapy planning strategy from a tumor-tracking beam's eye view.
    Li G; Cohen P; Xie H; Low D; Li D; Rimner A
    Phys Med Biol; 2012 Nov; 57(22):7579-98. PubMed ID: 23103415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploratory Study of 4D versus 3D Robust Optimization in Intensity Modulated Proton Therapy for Lung Cancer.
    Liu W; Schild SE; Chang JY; Liao Z; Chang YH; Wen Z; Shen J; Stoker JB; Ding X; Hu Y; Sahoo N; Herman MG; Vargas C; Keole S; Wong W; Bues M
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):523-533. PubMed ID: 26725727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Motion mitigation in intensity modulated particle therapy by internal target volumes covering range changes.
    Graeff C; Durante M; Bert C
    Med Phys; 2012 Oct; 39(10):6004-13. PubMed ID: 23039638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is an analytical dose engine sufficient for intensity modulated proton therapy in lung cancer?
    Teoh S; Fiorini F; George B; Vallis KA; Van den Heuvel F
    Br J Radiol; 2020 Mar; 93(1107):20190583. PubMed ID: 31696729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy.
    Pokhrel D; Sood S; Badkul R; Jiang H; McClinton C; Lominska C; Kumar P; Wang F
    J Appl Clin Med Phys; 2016 May; 17(3):277-293. PubMed ID: 27167284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of interplay effects on spot scanning proton therapy with motion mitigation techniques for lung cancer: SFUD versus robustly optimized IMPT plans utilizing a four-dimensional dynamic dose simulation tool.
    Yamano A; Inoue T; Yagihashi T; Yamanaka M; Matsumoto K; Shimo T; Shirata R; Nitta K; Nagata H; Shiraishi S; Minagawa Y; Omura M; Tokuuye K; Chang W
    Radiat Oncol; 2024 Sep; 19(1):117. PubMed ID: 39252032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Technical Note: Treatment planning system (TPS) approximations matter - comparing intensity-modulated proton therapy (IMPT) plan quality and robustness between a commercial and an in-house developed TPS for nonsmall cell lung cancer (NSCLC).
    Liu C; Yu NY; Shan J; Bhangoo RS; Daniels TB; Chiang JS; Ding X; Lara P; Patrick CL; Archuleta JP; DeWees T; Hu Y; Schild SE; Bues M; Sio TT; Liu W
    Med Phys; 2019 Nov; 46(11):4755-4762. PubMed ID: 31498885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Organ sparing potential and inter-fraction robustness of adaptive intensity modulated proton therapy for lung cancer.
    van der Laan HP; Anakotta RM; Korevaar EW; Dieters M; Ubbels JF; Wijsman R; Sijtsema NM; Both S; Langendijk JA; Muijs CT; Knopf AC
    Acta Oncol; 2019 Dec; 58(12):1775-1782. PubMed ID: 31556764
    [No Abstract]   [Full Text] [Related]  

  • 10. Impact of Spot Size and Spacing on the Quality of Robustly Optimized Intensity Modulated Proton Therapy Plans for Lung Cancer.
    Liu C; Schild SE; Chang JY; Liao Z; Korte S; Shen J; Ding X; Hu Y; Kang Y; Keole SR; Sio TT; Wong WW; Sahoo N; Bues M; Liu W
    Int J Radiat Oncol Biol Phys; 2018 Jun; 101(2):479-489. PubMed ID: 29550033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of respiratory motion on passively scattered proton therapy versus intensity modulated photon therapy for stage III lung cancer: are proton plans more sensitive to breathing motion?
    Matney J; Park PC; Bluett J; Chen YP; Liu W; Court LE; Liao Z; Li H; Mohan R
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):576-82. PubMed ID: 24074932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dosimetric comparison of distal esophageal carcinoma plans for patients treated with small-spot intensity-modulated proton versus volumetric-modulated arc therapies.
    Liu C; Bhangoo RS; Sio TT; Yu NY; Shan J; Chiang JS; Ding JX; Rule WG; Korte S; Lara P; Ding X; Bues M; Hu Y; DeWees T; Ashman JB; Liu W
    J Appl Clin Med Phys; 2019 Jul; 20(7):15-27. PubMed ID: 31112371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small-spot intensity-modulated proton therapy and volumetric-modulated arc therapies for patients with locally advanced non-small-cell lung cancer: A dosimetric comparative study.
    Liu C; Sio TT; Deng W; Shan J; Daniels TB; Rule WG; Lara PR; Korte SM; Shen J; Ding X; Schild SE; Bues M; Liu W
    J Appl Clin Med Phys; 2018 Nov; 19(6):140-148. PubMed ID: 30328674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiobiological and dosimetric impact of RayStation pencil beam and Monte Carlo algorithms on intensity-modulated proton therapy breast cancer plans.
    Rana S; Greco K; Samuel EJJ; Bennouna J
    J Appl Clin Med Phys; 2019 Aug; 20(8):36-46. PubMed ID: 31343826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dosimetric feasibility of 4DCT-ventilation imaging guided proton therapy for locally advanced non-small-cell lung cancer.
    Huang Q; Jabbour SK; Xiao Z; Yue N; Wang X; Cao H; Kuang Y; Zhang Y; Nie K
    Radiat Oncol; 2018 Apr; 13(1):78. PubMed ID: 29695284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Technical Note: Dosimetric evaluation of Monte Carlo algorithm in iPlan for stereotactic ablative body radiotherapy (SABR) for lung cancer patients using RTOG 0813 parameters.
    Pokhrel D; Badkul R; Jiang H; Kumar P; Wang F
    J Appl Clin Med Phys; 2015 Jan; 16(1):5058. PubMed ID: 25679161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensity-modulated proton and carbon-ion radiotherapy using a fixed-beam system for locally advanced lung cancer: dosimetric comparison with x-ray radiotherapy and normal tissue complication probability (NTCP) evaluation.
    Ming X; Mao J; Ma N; Chen J; Wang W; Sheng Y; Wu K
    Phys Med Biol; 2024 Jan; 69(1):. PubMed ID: 38064747
    [No Abstract]   [Full Text] [Related]  

  • 18. Limited Impact of Setup and Range Uncertainties, Breathing Motion, and Interplay Effects in Robustly Optimized Intensity Modulated Proton Therapy for Stage III Non-small Cell Lung Cancer.
    Inoue T; Widder J; van Dijk LV; Takegawa H; Koizumi M; Takashina M; Usui K; Kurokawa C; Sugimoto S; Saito AI; Sasai K; Van't Veld AA; Langendijk JA; Korevaar EW
    Int J Radiat Oncol Biol Phys; 2016 Nov; 96(3):661-9. PubMed ID: 27681763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosimetric impact of breathing motion in lung stereotactic body radiotherapy treatment using intensity modulated radiotherapy and volumetric modulated arc therapy [corrected].
    Rao M; Wu J; Cao D; Wong T; Mehta V; Shepard D; Ye J
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):e251-6. PubMed ID: 22365622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical implementation of intensity modulated proton therapy for thoracic malignancies.
    Chang JY; Li H; Zhu XR; Liao Z; Zhao L; Liu A; Li Y; Sahoo N; Poenisch F; Gomez DR; Wu R; Gillin M; Zhang X
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):809-18. PubMed ID: 25260491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.